Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 21 U.S.C. 355(n)(4) Michael Perry, M.D. Committee: Oncologic Drugs Advisory Committee - HRPC - Document - PDFSEARCH.IO

First Page	Meta Content
	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 21 U.S.C. 355(n)(4) Michael Perry, M.D. Committee: Oncologic Drugs Advisory Committee Add to Reading List Document Date: 2007-07-09 08:23:20 Open Document File Size: 27,25 KB Share Result on Facebook Company Less / Spectrum Pharmaceuticals / GPC Biotech AG / Johnson Matthey Pharmaceuticals / Johnson Matthey PLC / / Currency USD / / MedicalCondition prostate cancer / / MedicalTreatment chemotherapy / / Organization FDA / Oncologic Drugs Advisory Committee / / Person Michael Perry / / Technology chemotherapy / / SocialTag Satraplatin Johnson Matthey Chemistry GPC Biotech HRPC

Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 21 U.S.C. 355(n)(4) Michael Perry, M.D. Committee: Oncologic Drugs Advisory CommitteeAdd to Reading List